Home
/
Join Newsletter
/
Careers
/
Contact Us
About Us
Company Overview
Leadership
Pipeline
Overview
Clinical Trials
BioTherapeutics
SGX301 – for the treatment of Cutaneous T-Cell Lymphoma
SGX203 – Oral BDP for Treating Pediatric Crohn’s Disease
SGX942 Oral Mucositis
SGX201 – Oral BDP for Preventing Acute Radiation Enteritis
Vaccines / BioDefense
ThermoVax® – Thermostability Technology
RiVax® Ricin Toxin Vaccine
OrbeShield® for Gastrointestinal Acute Radiation Syndrome (GI ARS)
SGX943 – Therapeutic Emerging Infectious Disease
Reference Literature
Investors
Fact Sheet (pdf)
SGX94 (Dusquetide) Executive Summary (pdf)
Analyst Coverage
SEC Filings
Partnering
In-Licensing
Out-Licensing
News & Events
Current Releases
Relevant Publications
Search
SEC Filings
You are here:
Investors
>
SEC Filings
0
0
0
0
0
Please visit
the Soligenix page on XBRLFinancialWidget.com
for SEC filings.